Inventor · disambiguated record
Patrick R. Connelly
Also filed as: CONNELLY PATRICK · CONNELLY PATRICK R · CONNELLY PATRICK RAYMOND
14 granted patents·10 pending applications·540 citations·filing 1992–2022
94Inventor score
Top patents by PatentIndex Score
24 records- 0198US9670163B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·44 cites·8 claims
- 0298US9139530B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·64 cites·28 claims
- 0398US8754224B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 17, 2014·97 cites·18 claims
- 0497US10537565B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2018·Granted Jan 21, 2020·24 cites·26 claims
- 0597US9931334B2Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2017·Granted Apr 3, 2018·35 cites·17 claims
- 0696US8410274B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2012·Granted Apr 2, 2013·109 cites·22 claims
- 0793US9701639B2Co-crystals of modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Jul 11, 2017·41 cites·21 claims
- 0892US11291662B2Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2019·Granted Apr 5, 2022·5 cites·4 claims
- 0984US2023263794A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1082US5255976ATemperature gradient calorimeterVERTEX PHARMA·Filed 1992·Granted Oct 26, 1993·115 cites·24 claims
- 1172US8039475B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2007·Granted Oct 18, 2011·1 cites·8 claims
- 1269US8372846B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2011·Granted Feb 12, 2013·1 cites·10 claims
- 1362US7345048B2Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitorsPLIVA D D·Filed 2002·Granted Mar 18, 2008·4 cites·22 claims
- 1461US2011064811A1Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2006·Application pending·0 cites
- 1557US2024207270A1Compounds and compositions for modulating lipid metabolismWAVEBREAK INC·Filed 2022·Application pending·0 cites
- 1656US8492546B2Co-crystals and pharmaceutical compositions comprising the sameZHANG YUEGANG·Filed 2008·Granted Jul 23, 2013·0 cites·8 claims
- 1755US8759353B2Co-crystals and pharmaceutical compositions comprising the sameCONNELLY PATRICK R·Filed 2008·Granted Jun 24, 2014·0 cites·32 claims
- 1851US2002161599A1Electronic database of enzyme substrate and enzyme inhibitor structuresFiled 2001·Application pending·0 cites
- 1949US2007207512A1Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugsPLIVA D D·Filed 2006·Application pending·0 cites
- 2048US2003119061A1Structure-based drug design methods for identifying D-Ala-D-Ala ligase inhibitors as antibacterial drugsFiled 2002·Application pending·0 cites
- 2148US2008090847A1Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitorsPLIVA D D·Filed 2007·Application pending·0 cites
- 2248US2013274180A1Pharmaceutical CompositionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2344US2006089385A1Pharmaceutical compositionsCUI YONG·Filed 2005·Application pending·0 cites
- 2439US2006014813A1Pharmaceutical compounds that regenerate in vivoCONNELLY PATRICK·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick R. Connelly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →